Is there such a thing as international in Healthcare IT?

When I talk to investors, one of the most common question about healthcare IT is “how international is HIT”. The background to the question is of course simple: can you scale an HIT business beyond national boundaries or is the ceiling to growth what used to be the border bars before there was Schengen?The answer is simple. And complex. Almost like in real life.

It is simple, because in theory it should not be a problem to take a healthcare IT solution international. At the end of the value chain there is always a patient. There is always biology. And that is, with all its complexity, variability and unpredictability, the same wherever you come. It is complex and difficult everywhere. But it is the same complexity and difficulty everywhere too. If the French, the Germans, the Australians, Americans, to name but a few from which I have heard it, say: “we are so, so different!” – the truth is: they are not. Clinical practice, in my experience, is sometimes more different between one hospital and the next, between one ward (or senior physician) and the next, than it is between one country and the next. In other words, the true workflow differences are nominal in reality.

But then, why has hardly any EPR company achieved to go global? Why is there almost not a single seriously global platform? Even those, that earnestly tried to take a one-platform-strategy global, in all reality have failed. They may be in a handful of countries but have stopped to go further. Some are even backtracking. The companies that actually have a more global footprint – they do not have a one-platform-strategy. More a type of one-platform-per-country-strategy. Which gets us back to the question of why does it seem to be so difficult to go global?

The hidden reality is that it is not clinical practice, patient safety or workflow efficiency that drives EPR adoption. It is, sad and sober truth, reimbursement regulation. No hospital can run without being reimbursed for its services. And a hospital that does not comply with the way reimbursement is handled in a country, will not be able to live. Easy to comprehend.

Every country however – sometimes even different regions in the same country – has a different reimbursement system. Case based, DRG, volume based, KPI based, fee for service, mixtures of everything, you name it. Even the same thing is not the same. DRGs are to be found in most countries. How to calculate them however is different again wherever you look.

As payment for medical services is the textbook classic for a principal-agent-dilemma, what regulators do, in order to retain a level of (perceived) control over incoming bills and their relation to services rendered (note: not quality delivered), is to increase the documentation requirements to an ever more complex and detailed level. It is almost an arms race: helped by digitalisation, documentation has become easier, which led to regulators to ask for ever more documentation. Of course clinicians blame that vicious circle on EPRs and their cumbersome documentation routines. However, the real challenges comes from the reimbursement driven statutory documentation requirements, which are different in every country, unpredictable and grow in random pace and random areas – which makes it so difficult to bring structure, reason and simple workflow concepts to bear. The complexity is such, that not even flexible template tools are enough, architecture matters! Where cases are enough in one country, case sub-segments are needed in others.  

Now, back to the question of internationalisation. If my theory is true and reimbursement drives documentation routines, which drive workflows, which drive layout and customisation of EPRs, then it is very difficult indeed to internationalise an EPR. You would have to design a catch all architecture and granular datamodel with a very flexible workflow and template engine and at the same time hardened rigour around design principles, terminology and data concepts. And then it would be possible to have one platform for the world. In theory not a problem. In practice however… in practice all EPR platforms have been built for a home market with all its design decisions and restrictions, and then, because they work well, you try to take it global. That has proven very tough to anyone who tried.

There is another truth in this though. The further you stray from billing rules and reimbursement-driven documentation, the more consistent workflows become across country boundaries. Departmental systems that are very close to the reimbursement cycle are still almost as local as EPRs usually are. Theatre solutions, A&E and the like are still very local businesses. Yet procedures, that are not really part of the reimbursement calculation, like imaging, labs, cardiology, and many other specialties, are areas, where systems become more and more international and even global.

The answer to the question hence is simple: if you have a catch-all datamodel with a powerful and flexible documentation engine, internationalising an EPR is possible. If you designed it with the end in mind. And provided you acquire the necessary local knowledge on reimbursement requirements and intricacies.

If you work in specialty areas, whose workflows are a distance away from billing cycles, then you can deploy global best practices much more easily. And clinicians, who are otherwise hesitant to change their workflows, will be interested in how to improve their processes. When billing is not impacted, clinical practice actually does become innovative.

Technology and IT Trends in Healthcare 2020

It is not an exact science attempting to forecast future trends. Yet many stakeholders welcome the assistance that the trend analysis industry brings –  giving some order and insight into the noisy jungle of innovation, disruption and opportunities. Healthcare technology is no different in this respect. When reviewing and collating the various trend predictions for […]

Read more

The Importance of Blended Finance in Achieving SDGs and Directing Private Capital to ESG Projects

To achieve mandated Sustainable Development Goals (SDG’s) by 2030 and facilitate the growth of Environmental, Social and Governance (ESG) opportunities globally a substantial increase in investment is needed – from infrastructure projects like schools, hospitals, broadband networks, pipelines and roads to funding innovative national healthcare and technology initiatives.

Read more

What drives change in Healthcare?

Healthcare impacting dynamics and secular trends Healthcare – big, complex, labour driven, dominated by science, public and private, digitalized and yet still recessive, awe inspiring, (com-) passionate, mission critical, charitable and being a huge corporate industry globally. It’s so many things and fits so few stereotypes that sometimes it feels like a universe in itself. […]

Read more

Digitalisierung ist nicht die Frage. Prozessmanagement schon.

by Holger Cordes Seit einer halben Generation werden Wahlprogramme mit dem Vorhaben der „Digitalisierung“ verschönert. Es gibt nationale Großprojekte wie die sprichwörtliche „Telematik-Infrastruktur“. Die Digitalisierung wird inzwischen von Staatssekretären vorangetrieben, demnächst von eigenen Ministerien. Und gleichzeitig erleben wir für unser Gemeinwesen in den letzten 12 Monaten eine regelrechte digitale Götterdämmerung. Ob in Schulen und Universitäten, […]

Read more

It is the workflow, and not the tech!

Nearly forty years into digitalising healthcare has been a beneficial journey. Yet there also is a feeling of shortcoming, missed opportunity and backwardness when it comes to many people’s perception of where we are today. It is a sobering position to be in, given the promises and especially the opportunities. And while there is even […]

Read more

The transformation chasm

Genius is 10% inspiration and 90% transpiration. We all know that. Change, even more so transformational change, is 10% strategy and 90% psychology. Yet, like with genius, we keep ignoring it, even as we very well know it. Discounting the drudgery in retrospect for a “heureka”-moment is understandable. But why are we discounting psychology so […]

Read more

Copyright © 2022 neoqua | Designed & built by